Luedeking-Piret Model Advances Multi-Step mAb Forecasting
In the rapidly evolving landscape of biopharmaceutical manufacturing, monoclonal antibodies (mAbs) have surged to the forefront as indispensable therapeutic agents. ...
In the rapidly evolving landscape of biopharmaceutical manufacturing, monoclonal antibodies (mAbs) have surged to the forefront as indispensable therapeutic agents. ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine